PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 34920168-1 2022 Bisphosphonates are effective in reducing hip and other fractures. Diphosphonates 0-15 hedgehog interacting protein Homo sapiens 42-45 35561128-11 2022 In conclusion, bisphosphonate use, especially persistence to intravenous bisphosphonates (e.g., zoledronic acid), may reduce post-fracture mortality among osteoporosis patients, particularly those with hip/vertebral fractures. Diphosphonates 15-29 hedgehog interacting protein Homo sapiens 202-205 34534754-3 2021 Bisphosphonates preserve bone mineral density at the hip but not at the knee, which is the anatomical site most prone to fracture in the SCI population. Diphosphonates 0-15 hedgehog interacting protein Homo sapiens 53-56 34585781-0 2022 Total Hip Bone Mineral Density as an Indicator of Fracture Risk in Bisphosphonate-Treated Patients in a Real-World Setting. Diphosphonates 67-81 hedgehog interacting protein Homo sapiens 6-9 33386876-2 2021 Our meta-analysis of studies shows that early bisphosphonate administration after SCI was safe and beneficial to the BMD of the total hip and lumbar spine at 12 months. Diphosphonates 46-60 hedgehog interacting protein Homo sapiens 134-137 35279261-3 2022 Bisphosphonates are the most widely used anti-resorptives, reducing bone turnover markers to low premenopausal concentrations and reducing fracture rates (vertebral by 50-70%, non-vertebral by 20-30%, and hip by ~40%). Diphosphonates 0-15 hedgehog interacting protein Homo sapiens 205-208 33386876-10 2021 RESULTS: There were significant differences in BMD of the total hip and lumbar spine or serum C-terminal telopeptide between the bisphosphonate and control groups but no difference in adverse events. Diphosphonates 129-143 hedgehog interacting protein Homo sapiens 64-67 33386876-14 2021 CONCLUSION: Early bisphosphonate administration after SCI was safe and beneficial to the BMD of the total hip and lumbar spine at 12 months. Diphosphonates 18-32 hedgehog interacting protein Homo sapiens 106-109 31828096-6 2019 Overall in the pairwise meta-analyses, bisphosphonate use significantly reduced the risk of new vertebral, hip, and nonvertebral nonhip fractures, with ORs and 95% confidence intervals of 0.56 (0.49-0.64), 0.69 (0.48-0.98), and 0.82 (0.70-0.97), respectively. Diphosphonates 39-53 hedgehog interacting protein Homo sapiens 107-110 33479844-3 2021 In our population including 14,990 women and 13,239 men, use of bisphosphonates reduced risk of fractures in hip and forearm in women. Diphosphonates 64-79 hedgehog interacting protein Homo sapiens 109-112 33479844-5 2021 INTRODUCTION: The objective was to examine if treatment with bisphosphonates (BPs) was associated with reduced risk of fractures in the hip and forearm in women and men in the general population. Diphosphonates 61-76 hedgehog interacting protein Homo sapiens 136-139 33479844-5 2021 INTRODUCTION: The objective was to examine if treatment with bisphosphonates (BPs) was associated with reduced risk of fractures in the hip and forearm in women and men in the general population. Diphosphonates 78-81 hedgehog interacting protein Homo sapiens 136-139 29932001-0 2019 Locally administered bisphosphonate in hip stem revisions using the bone impaction grafting technique: a randomised, placebo-controlled study with DXA and five-year RSA follow-up. Diphosphonates 21-35 hedgehog interacting protein Homo sapiens 39-42 21145521-13 2010 CONCLUSIONS: In this retrospective study, it was found that treatment with oral bisphosphonates significantly increases BMD at the hip in postpolio patients. Diphosphonates 80-95 hedgehog interacting protein Homo sapiens 131-134